alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc6S

Term ID

CHEBI:62342

Synonyms

6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-6-O-sulfo-beta-D-glucopyranose
6-deoxy-alpha-L-galactosyl-(1->2)-beta-D-galactosyl-(1->4)-2-acetamido-2-deoxy-6-O-sulfo-beta-D-glucose
alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-beta-D-GlcNAc6S
alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-6-O-sulfo-beta-D-glucosamine
Fuca1-2Galb1-4(6S)GlcNAcb
Fucalpha1-2Galbeta1-4(6S)GlcNAcbeta
O-6-deoxy-alpha-L-galactopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose, 6-(hydrogen sulfate)

Definition

α-L-Fucp-(1→2)-β-D-Galp-(1→4)-D-GlcpNAc6S in which the configuration at the anomeric centre of the glucosamine residue is β.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc6S

Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc6S

Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc6S

Phenotype affecting alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc6S

Human Disease Model